The Eurecat technology centre is studying the effectiveness of a new therapy based on a multi-ingredient amino acid to ameliorate the impact of obesity and non-alcoholic fatty liver disease in the health of menopausal women. Specifically, Eurecat’s Nutrition and Health Unit is to run a three-month nutritional intervention with menopausal women to investigate how [...]
The European HYPIEND project, coordinated by the Eurecat technology centre, is studying the impact of endocrine disruptors on the hormonal system during pregnancy, the first 18 months of a baby’s life and during pre-puberty to gain the understanding needed to devise strategies to minimise exposure to these chemicals and minimize their adverse effects on [...]
The Eurecat technology centre is this week showcasing at the Mobile World Congress an assistive robot which helps people at home with a range of daily tasks and can hold a conversation and offer personalised care to users based on monitoring their state of health or mood, furnishing for example instructions for an exercise [...]
The Eurecat technology centre is presenting this week at the Mobile World Congress a headband developed together with Time is Brain to record brain activity in real time during an acute stroke and predict complications early on. The innovation is part of the BraiN20® portable medical device which provides the patient with “quicker access [...]
The PHASAL project is fashioning new biodegradable bioplastics from agri-food waste for medical applications such as transdermal patches and suture kits which will minimise their environmental impact. Specifically, it is to develop new grades of biodegradable plastics (PHA) obtained from the recovery of organic waste, thus affording them advanced processability and biocompatibility properties, which [...]
The Eurecat technology centre has over 200 patents for highly innovative industrial, digital, biotech and sustainability technologies and has set up nine spin-offs in partnership with other businesses as one of its core technology transfer activities in areas such as digitalising healthcare, textile production, 3D printing and information and communication technologies. To publicise these and other [...]
The burgeoning potential of generative artificial intelligence is set to play a leading role in the healthcare industry in 2024 along with gene editing and its applications in precision medicine and synthetic biology. This will enable the generation of new ingredients for the food sector and bioactive substances for the pharmaceutical industry to unlock [...]
The Eurecat technology centre predicts that 2024 will be the year of exploiting generative artificial intelligence which will yield solutions developed for a wide range of sectors including healthcare, construction, manufacturing, education, finance, retail and government. Daniel Casellas, Eurecat’s scientific director, notes “the enormous potential which is opening up to ensure that new technological [...]
The Centre for Omic Sciences, a joint Eurecat technology centre and Rovira i Virgili University unit, has underscored at the COS 2023 Annual Symposium held in Reus and online the potential of nuclear magnetic resonance (NMR) and for studying people’s biomarkers to unlock personalised nutrition and medicine. Nuclear magnetic resonance (NMR) “is an analytical [...]
The Eurecat technology centre is working in the European OPADE project for the identification of key biomarkers in major depressive disorder to support healthcare professionals in their decision-making and increase the accuracy of diagnosis and antidepressant treatment. Specifically, the Eurecat research team is analysing multi-omics data from hundreds of patients with severe depression “to find [...]
